vimarsana.com
Home
Live Updates
STRATA Study to Validate Cxbladder Utility Reaches 50% Enrol
STRATA Study to Validate Cxbladder Utility Reaches 50% Enrol
STRATA Study to Validate Cxbladder Utility Reaches 50% Enrolment
Hershey, PA (PRWEB) 8 July 2022 (PRWEB) July 07, 2022 -- Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) today announces it has reached more than 50%
Related Keywords
United States ,
New Zealand ,
Canada ,
American ,
Peter Meintjes ,
American Urological Association ,
Pacific Edge Limited ,
Pacific Edge ,
Safe Testing ,
Asymptomatic Microhematuria ,
Edge Chief Executive Dr Peter Meintjes ,
Hedge Limited ,
Press Release ,